Regulatory Effects and Mechanisms of L-Theanine on Neurotransmitters via Liver–Brain Axis Under a High Protein Diet
- 2 September 2023
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 61 (2) , 783-798
Abstract
Excessive protein intake causes liver and brain damage and neurotransmitter disorders, thereby inducing cognitive dysfunction. L-theanine can regulate the neurotransmitter content and show great potential in liver and brain protection. However, it remains unclear whether l-theanine effectively regulates neurotransmitter content under high-protein diet. A 40-day feeding experiment was performed in Sprague Dawley rats to investigate the regulatory effects and mechanisms of l-theanine on neurotransmitters via liver–brain axis in high-protein diets. The results showed that a 30% protein diet increased the liver and brain neurotransmitter content while maintaining the normal structure of liver and the hippocampal CA1 of brain and improving the autonomous behavior of rats. In contrast, 40% and 50% protein diets decreased the content of neurotransmitters, affected autonomous behavior, destroyed the hippocampal CA1 of brain structure, increased hepatic inflammatory infiltration, lipid degeneration, and hepatocyte eosinophilic change in liver, increased liver AST, ALT, MDA, CRP, and blood ammonia level, and decreased liver SOD and CAT level. However, l-theanine improved liver and brain neurotransmitter content, autonomous behavior, liver and hippocampal brain structure, and liver biochemical indicators in 40% and 50% protein diets. To explore how LTA can eliminate the adverse effects of a high-protein diet, we analyzed different metabolites and proteomes and using western blotting for validate quantitatively. We found that l-theanine regulates the activity of PF4 and G protein subunit alpha i2, increases the content of brain-derived neurotrophic factor and dopamine under a 20% protein diet. In addition, l-theanine can activate the adenylate cyclase-protein kinase A pathway through the protein alpha/beta-hydrolase domain protein 12 to regulate the content of neurotransmitters under a 40% protein diet, thereby exerting a neuroprotective effect.Keywords
All Related Versions
This publication has 59 references indexed in Scilit:
- The role of glutamate and its receptors in multiple sclerosisJournal of Neural Transmission, 2014
- The liver–brain axis in liver failure: neuroinflammation and encephalopathyNature Reviews Gastroenterology & Hepatology, 2013
- ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARCProceedings of the National Academy of Sciences, 2013
- Genetic Markers of Comorbid Depression and Alcoholism in WomenAlcohol, Clinical and Experimental Research, 2012
- Alanine and aspartate aminotransferase and glutamine-cycling pathway: Their roles in pathogenesis of metabolic syndromeWorld Journal of Gastroenterology, 2012
- The microtubule cytoskeleton acts as a key downstream effector of neurotransmitter signalingSynapse, 2010
- Roles of glutamine in neurotransmissionNeuron Glia Biology, 2010
- β-Alanine as a small molecule neurotransmitterNeurochemistry International, 2010
- Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosisThrombosis Research, 2010
- Expression of brain‐derived neurotrophic factor immunoreactivity and mRNA in the hippocampal CA1 and cortical areas after chronic ischemia in ratsJournal of Neuroscience Research, 2004